Oncorus
Cambridge, US · Founded 2015 · Delaware corporation · 7 employees on LinkedIn · 4 known investors
Find your way into Oncorus
91 people in our graph share verified history with the Oncorus team — schools, employers, funds. One of them is your warm intro.
Constant Beroulleunlockedknows Christophe Queva · together at BPI France (overlapped)
×2knows the team · via DEM Biopharma, Inc.
×8knows the team · via BPI France
knows the team · via University of Lille 1 Sciences and Technology
Founders & leadership
CQ
Christophe QuevainExecutiveChristophe Queva has held R&D leadership roles at AstraZeneca, Amgen, and Gilead Sciences, where he directed translational science for an approved oncology therapy, and has served as President, CEO, or Chief Scientific Officer at biotech firms including Triptych Therapeutics, Egle Therapeutics, and iTeos. He brings over two decades of experience in oncology and immuno-oncology program development, regulatory strategy, and organizational building, with additional board experience at Bpifrance.
TA
Theodore AshburnNamed on SEC filing
AL
Alon LazarusNamed on SEC filing
CW
Board
BM
MF
LE
Investors · 4
Reported raises · per SEC filings
Form D private placements$115.1M disclosed across 2 rounds · 2016–2019
▶$53.8MraisedDec 2019 · 30 investors · OtherRule 506(b)
▶$53.8MraisedDec 2019 · 30 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Theodore AshburnExecutive Officer, Director
- Briggs MorrisonDirector
- Mitchell FinerDirector
- Cameron WheelerDirector
- Mary Kay FentonDirector
- Robert KirkmanDirector
- Spencer NamDirector
- Christophe QuevaExecutive Officer
- John McCabeExecutive Officer
- Luke EvninDirector
- Offering amount
- $89.6M
- Amount sold
- $53.8M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$61.3MraisedSep 2018 · 17 investors · OtherRule 506(b)
▶$61.3MraisedSep 2018 · 17 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Briggs MorrisonDirector
- Theodore AshburnExecutive Officer, Director
- Mitchell FinerExecutive Officer, Director
- Alon LazarusDirector
- Cameron WheelerDirector
- Luke EvninDirector
- Christophe QuevaExecutive Officer
- Offering amount
- $61.4M
- Amount sold
- $61.3M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Oncorus went on to found or lead other companies.
In the news
Frequently asked questions
- Who are Oncorus's investors?
- Oncorus's investors include Astellas Venture Management LLC, Cowen Healthcare Investments, Deerfield Management Company, MPM BioImpact.
- How much funding has Oncorus raised?
- Oncorus has disclosed $115.1M raised across 2 rounds.
- Where is Oncorus headquartered?
- Oncorus is headquartered in Cambridge, US.